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Available online 10 January 2012AbstractParacoccidioidomycosis is a systemic granulomatous disease caused by the dimorphic fungus Paracoccidioides brasiliensis. Its major antigen
is a 43 kDa glycoprotein whose peptides embody different functions: P10 peptide, a T-cell epitope, induces protective response while P4 and P23
peptides inhibit both, macrophage functions and inflammatory reaction, thus facilitating infection. Here we investigated the modulating
mechanisms of the immune response exerted by P4 and P23 involved in the latter inhibitory effect on macrophages. Moreover we analyzed the
peptides effects in different models in vivo. While evaluating whether P4 and P23 present systemic anti-inflammatory effects in vivo, we showed
that their intraperitonial administration decreased footpad swelling in mice infected with either P. brasiliensis or Mycobacterium bovis. Both,
qPCR and ELISA assays suggested that this anti-inflammatory effect depended on alterations in the kinetics of production of innate immunity
modulators such as TNF-a, IL6, IL10 and TLR2. IL10 seems to be early produced than TNF-a and IL6, produced later in presence of peptides.
Higher doses or intravenously given P4 and P23 resulted in earlier and more prolonged anti-inflammatory effects. Moreover, continuous
treatment with P4 and P23 sustained the anti-inflammatory activity throughout.
 2012 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
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Paracoccidioidomycosis (PCM) is a systemic granuloma-
tous disease caused by the dimorphic fungus Paracoccidioides
brasiliensis. PCM is prevalent in Brazil and other Latin
American countries [1e3]. The acute or subacute form of
PCM affects both genders, predominantly male, and chiefly
involves the reticuloendothelial system. The acute form is
characterized by impaired cellular immunity, negative
delayed-type hypersensitivity reactions, increased systemic
proliferation of the fungus, and high mortality rates. The
chronic form affects mainly adult males with predominantly* Corresponding author. Rua Botucatu 862, 4th floor, 04023-901, Sa˜o Paulo,
Brazil. Tel.: þ55 11 55496073; fax: þ55 11 555723328.
E-mail address: jdlopes@unifesp.br (J.D. Lopes).
1286-4579/$ - see front matter  2012 Institut Pasteur. Published by Elsevier Ma
doi:10.1016/j.micinf.2011.12.012pulmonary and/or mucocutaneous involvement [4]. This form
shows exacerbated host cellular immune responses and
formation of granulomas containing fungal cells and may
develop extensive sequels, including fibrotic lesions and
impairment of lung function [3,5]. Cellular immunity is the
host most important defense mechanism against both experi-
mental and human PCM [6,7].
The glycoprotein gp43 from P. brasiliensis [8,9], is the
main PCM diagnostic antigen [10], being recognized by 100%
of sera from infected patients [11,12]. This antigen was firstly
described as an adhesion protein for its capacity of binding to
matrix extracellular components, such as laminin [13,14].
Gp43 plays different roles in the pathogenesis P. brasiliensis.
It strongly stimulates in vitro granuloma-like formation by B-1
cells and macrophages [15]. Moreover, a peptide named P10
(QTLIAIHTLAIRYAN), derived from its sequence, mediates
specific T-cell activation, leading to protection against PCM.sson SAS. All rights reserved.
518 F.T.C. Konno et al. / Microbes and Infection 14 (2012) 517e527In mice it elicits an interferon-gamma (IFN-g) dependent
immune protection and immunization with P10 improved the
therapeutic effectiveness when combined with antifungal
drugs [5,16,17]. Contrarywise, gp43 participates in the
installation mechanisms of primary infection by inhibiting
both, phagocytosis and fungal intracellular killing [18]. Some
endogenous peptides, named Antimicrobial Peptides (AMPs),
can act as immune modulators and their production may
depend on the host immune response to infections, involving
inflammation and vascular effects [19]. Considering that the
gp43 molecule induces inhibition of phagocytosis [18,20],
Konno et al. [21] demonstrated that two peptides derived from
gp43, named P4 and P23, inhibit phagocytosis of zymosan
particles and P. brasiliensis yeasts by macrophages. NO is
related with the killing capacity of macrophages [22] and its
production is also inhibited by P4 and P23. In vivo experi-
ments showed that local administration of the peptides in mice
infected with P. brasiliensis or BCG promoted decrease of
footpad inflammation [21].
Considering the immune modulator function of some
AMPs and the inhibitory effect of P4 and P23 on macrophages
[21], and assuming that these findings could bear some
correlation, we herein investigated mechanisms through which
P4 and P23 down-regulate macrophage functions and inflam-
matory response. Moreover, we used P4 and P23 with different
treatment protocols in vivo to determine the schedule by which
they may produce best results in mice.
2. Materials and methods2.1. Peptide synthesis and purificationPeptides were kindly synthesized by MA Juliano, Federal
University of Sao Paulo (UNIFESP), SP, Brazil, by the
9- fluoroenylmethoxycarbonyl technique as described by
Atherton and Sheppard [25], with an automated benchtop
simultaneous multiple solid-phase peptide synthesizer (PSSM 8
system; Shimadzu, Tokyo, Japan). The amino acid sequences are
NLGRDAKRHLSKHWDTFITEDDFKNIAAAGL (P4) and
AFEVGAGWYFWTWKTEGAPGWDMQD (P23). Abbrevia-
tions for amino acids and nomenclature of peptide structures
followed the recommendations of the IUPAC-IUB (Commission
on Biochemical Nomenclature) [26].2.2. MiceMale Balb/c and C57/Bl6 mice, 6-8 week-old, were obtained
from the animal facility of Federal University of Sa˜o Paulo
(UNIFESP), SP, Brazil.MaleKO-IL10 andCAFmice, 6-8week-
old, were bred and maintained in the facility of the Discipline of
Immunology, UNIFESP. Animals were euthanized according to
Guide for the Care and Use of Laboratory Animals (NIH guide).2.3. Bone marrow-derived macrophages (BMM)BMM were generated as previously described [27] from
6-to 8-week-old Balb/c mice. Cultures were kept at 37 C inthe presence of 5% CO2 in RPMI supplemented with 10%
fetal bovine serum and 5% of conditioned medium from
cultures of L929 cells, known to be high producers of MCSF.
Differentiated macrophages were maintained in culture or
were counted and plated at 2106 cells/well onto a 6-well
tissue culture plate.2.4. Phagocytic testDifferentiated BMM were challenged with zymosan parti-
cles (Sigma, 2 mg/ml) with or without P4 or P23 (5 mg/ml)
after incubation at 37 C for 2, 4, 8 or 12 h. Afterward, culture
supernatants were harvested, kept at 70 C and analyzed for
cytokines and NO. Cells were then rinsed with PBS for
removal of non-internalized zymosan. RNA was isolated from
BMM for PCR quantitative assays.2.5. Isolation of total RNA and cDNA synthesisTotal RNA was isolated from fresh differentiated BMM
disrupted in the presence of Trizol reagent (Invitrogen),
following the manufacturer’s instructions. Contaminating
DNA was digested with RNAse-free DNAse I (Promega), as
described [28]. RNA samples were quantified using a Nano-
Drop apparatus (Thermo Scientific, USA), analyzed for
integrity in formaldehyde agarose gels and stored at 70 C in
Dimethyl pyrocarbonate (DEPC)-treated water. cDNA
synthesis was made from 3 mg of total RNA with SuperScript
II reverse transcriptase kit (Invitrogen), as described [29].2.6. Quantitative RT-PCR (qPCR)For experiments of quantitative RT-PCR SybrGreen based
system of detection was used (Applied Biosystems, USA), as
described by [30]. Briefly, for detection of IL6, IL10, TNF-a
and Toll-like receptor 2 expression levels, the reactions were
carried out using 2 mM of sense and antisense primers for each
gene and GAPDH primers as endogenous control, 10 ml of the
SybrGreen PCR master mix (Applied Biosystems) and 3 ml of
cDNA diluted 2.5 (synthesized from 3 mg of total RNA). As
recommended for relative quantification experiments using
ΔΔCt method [31], for each gene tested were standardization
experiments carried out to validate and evaluate the efficiency
of the amplification reaction. In these experiments cDNA of
zymozan-stimulated macrophages were used and standard
curves were constructed using serial dilutions of the cDNA
from pure to 1:16. Efficiencies of the amplification reactions
were calculated using the equation E ¼ (10e1/slope)  100
and were accepted only the reactions that had efficiency from
90% to 100%. Moreover, validation experiment was per-
formed comparing the standard curves of the target genes and
endogenous control, as preconized [32]. Sequences for PCR
primer sets (IL6, IL10, TNF-a and Toll-like receptors 2 and 4)
were previously designed as recommended and the sequences
are shown in supplementary table [33]. Cycling was carried
out in an ABI Prism 7500 Sequence Detection System
(Applied Biosystems, USA) starting with one cycle of 50 C
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(15 s) and 60 C (1 min). The melting curve was determined
with an additional cycle of 95 C (15 s), 60 C (20 s) and
95 C (15 s). Reactions were performed in triplicates, and the
endogenous control (GAPDH) was used as calibrator. Relative
expression was measured using ΔΔCt method and calculations
were performed as described [34]. Results are representative
of 3 individual experiments.2.7. Cytokine analysisCytokine concentrations were measured in culture super-
natants using ELISA kits for TNF-a, IL-6 and IL-10
(eBioscience) according to the manufacturer’s protocol.
Results are representative of 3 individual experiments, all
made in triplicates.2.8. Analysis of cell phenotypeBMM were stained with monoclonal antibodies and
analyzed by flow cytometry using a FACSCalibur System
(BD Biosciences). The following primary antibodies were
used: phycoerythrin (PE) rat anti-mouse CD11b (BD Biosci-
ences), allophycocyanin (APC) rat anti-mouse TLR2. Cell
staining was carried out according manufacturer’s protocol.
Results are representative of at least 2 individual experiments
made using triplicates.2.9. Influence of peptides on the inflammatory responseThe systemic influence of peptides on the inflammatory
response was evaluated by inoculation of Mycobacterium
bovis (bacillus Calmette Guerin/BCG, Butantan Institute, Sa˜o
Paulo, Brazil), at a concentration of 100 mg/ml, or P. brasi-
liensis cells in the subcutaneous tissue of the dorsal region of
the footpad of male mice (106 CFU of BCG or 2  106 P.
brasisliensis cells, respectively). Five groups of male Balb/c
mice (6e8 weeks old), were used. Treatment by intraperito-
neal or intravenous routes with P4 or P23 at concentrations of
100 or 200 mg were used in test groups. The kinetics of the
inflammatory response was evaluated by dial thickness gauge
(Mitutoyo) at different time intervals (30 min, 2, 4, 8, 12, 24 h
and every 24 h for 7 days) [35]. Results are representative at
least 2 individual experiments with 5 animals per group.2.10. HistopathologyGroups of 5 Balb/c mice, CAF mice, C57/bl6 mice and
KO-IL10 mice were infected in the footpads with P. brasi-
liensis or BCG and killed after 8 h. The infected footpads were
excised, fixed in 12% buffered formalin, and embedded in
paraffin. Sections were stained with hematoxylin-eosin or
Grocott method and examined microscopically (Nikon,Tokyo,
Japan). Quantification of area with P. brasiliensis was done in
sections stained with Grocott by Image J software (5 slides/30
fields per slide).2.11. Statistical analysisResults were expressed as the mean  the standard devia-
tions (SD). Data were analyzed by unpaired Student’s t test
with Welch’s correction (two-tailed) used for comparison of
the two groups when the data met the assumptions of the t
tests. Analysis of variance (ANOVA) followed by the
TukeyeKramer test was sometimes applied (INSTAT soft-
ware, GraphPad, San Diego, CA). P values under 0.05 indi-
cated statistical significance.
3. Results3.1. Systemic anti-inflammatory effect of P4 and P23Considering the inhibitory effect of P4 or P23 in inflam-
mation observed in vitro and in vivo [21], we investigated
whether these peptides had any systemic effect in vivo on the
kinetics of inflammation elicited by P. brasiliensis cells inoc-
ulated into the subcutaneous tissue of the animals. To show
systemic activity, 100 mg of peptides P4 and P23 were given
intraperitoneally together with the footpad challenge with
yeasts of P. brasiliensis. Results showed decrease in footpad
swelling test (FPT) indexes in the first 12 h after inoculation of
P. brasiliensis cell (Fig. 1A). In Balb/c mice, decrease in FPT
was significant after 8 h of infection with peptides treatment and
was maintained until 12 h (Fig. 1A). Histological analysis to
determine area with P. brasiliensis (Fig. 1B above) on the
footpad of the infected mice and quantification of fungus per
field (Fig. 1B below) showed that the treated groups presented
higher amounts of fungi. Histological analysis with HE showed
no difference (data not shown). These results confirm results of
Konno et al. (2009) [21] suggesting that P4 and P23 inhibit the
phagocytic ability of macrophages, thereby facilitating fungal
growth. Additionally, we did tests of FPT swelling using CAF
mice that are assumed as having exacerbated inflammatory
reactions. We infected their footpad either with P. brasiliensis
cells or BCG and the mice were treated or not with P4 or P23.
We observed that P4 and P23 led to significant decrease in FPT
swelling indexes after 4 h of infection with treatment. This
effect was maintained for 12 h (Fig. 2A,B). Histological anal-
ysis of infected footpads showed again areas with higher
amounts of yeasts in treated groups (Fig. 2C). Histological
analysis with HE showed no difference (data not shown). Thus,
P4 and P23 presented systemic anti-inflammatory effect and
seemed to inhibit the phagocytic ability of macrophages thereby
facilitating fungal growth.3.2. Influence of peptides on the pro-inflammatory
cytokinesTo understand the immunoregulatory phenomena involved
in the action of P4 and P23, we performed analysis of mRNA
expression of inflammatory and pro- inflammatory molecules
produced by macrophages. The levels in expression of the
transcripts of TNF-a, IL10, IL6 and Toll like receptor 2 were
evaluated in macrophages stimulated with zymosan in vitro in
Fig. 1. Systemic effect of treatment with P4 and P23 on the evolution of P. brasiliensis cells-induced edemas in the footpads of mice (n ¼ 5 per group). (A) Footpad
swelling of Balb/c infected with P. brasliensis and treated with P4 or P23 (A). Negative control (Cneg), P4 control (CP4) and P23 control (CP23) groups received
PBS in footpad and intraperitoneal treatment with PBS, P4 or P23 respectively. Positive control (Cpos), P4 and P23 groups was infected P. brasiliensis and treated
intraperitonealy with PBS, P4 or P23 respectively. (B) Histological analyses of P. brasiliensis cells stained by Grocott (100). (B) Quantification of area with P.
brasiliensis cells were done with Image J software. P* < 0.05, P** < 0.01 and P*** < 0.001 when values were compared with control group.
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evaluated 2 and 8 h after stimulation and treatment with
peptides.
We observed that P4 and P23 promoted increased TNF-a
mRNA 2 h after stimulation with zymosan particles; however,
after 8 h stimulus, there was no difference in expression of
TNF-a between groups (Fig. 3A). To confirm these results,
ELISA was performed to quantify TNF-a production by
macrophages after 2, 4, 8 and 12 h of treatment with peptides
and stimulation. Corroborating with mRNA expression results,
groups only stimulated with zymosan particles had increased
production of TNF-a as early as 2 h. Groups treated with P4 and
P23 showed similar rise only after 4 h of the stimulus (Fig. 3B).
Thus, P4 and P23 promoted increase expression of TNF-a gene
after 2 h of stimulation and this effect seems to result in
increased production of TNF-a after 4 h (Fig. 3B). Contra-
rywise, macrophages stimulated with zymosan particles
increased secretion of TNF-a earlier (2 h). These results suggest
that P4 and P23 promoted a noticeable delay in the production
of TNF-a by macrophages.P4 and P23 also had influence in mRNA expression of IL6.
In the presence of peptides we observed increase of IL6
mRNA expression 8 h after the stimulation (Fig. 3C). As for
P23, 2 h only were needed to promote similar expression
(Fig. 3C). This resulted in significant increase of IL6
production after 8 h in groups treated with P4 and P23 while
the production of IL-6 by the control group showed no alter-
ation in any of the evaluated times (Fig. 3D).3.3. Influence of P4 and P23 on IL10IL10 is the most important cytokine with anti-inflammatory
properties [36,37]. Analysis by qPCR showed that P4 and P23
promoted increase in expression of IL10 mRNA after 2 h of
the stimulation with zymosan particles (Fig. 4A). P23 main-
tained this higher level up to 8 h (Fig. 4A). Production of IL10
by macrophages seems more precocious in groups treated with
P4 and P23 since macrophages in the control group only
promoted a small increase in levels of IL-10 8 h after stimu-
lation (Fig. 4B). Moreover, experiments in vivo with infection
Fig. 2. Systemic effect of treatment with P4 and P23 on the evolution of P. brasiliensis cells-induced edemas (A) or BCG (B) In the footpad of mice (n ¼ 5 per
group). CAF mice were used in these experiments. Negative control groups (Cneg), received PBS in their footpad and were treated intraperitonealy with PBS.
Positive control (Cpos), P4 and P23 groups were infected P. brasiliensis (A) or BCG (B) and treated intraperitonealy with PBS, P4 or P23 respectively. (C)
Histological analyses of P. brasiliensis cells stained by Grocott (100). Quantification of area with P. brasiliensis cells were done with Image J software.
P* < 0.05, P** < 0.01 and P*** < 0.001 when values were compared with control group.
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this lineage, P4 and P23 had no anti-inflammatory effect since
comparison in FTP swelling between control and treated
groups was not different (Fig. 4C,D).3.4. Influence of peptides on the molecules involved in
inflammationIn addition to genes related to pro- and anti-inflammatory
cytokines we also checked the expression of molecules
involved in innate immunity as Toll like receptor 2 (TLR2)
and NO. Analysis of gene expression demonstrated that
mRNA of TLR2 was not significantly different between
peptide treated and control groups (data not shown). However,
we verified by flow cytometry analysis performed with BMM
in 2, 4, 8 and 12 h after incubation with zymosan and peptides
that expression of TLR2 was a little delayed in treated groups
as compared to the control group (data not shown).
Moreover, as shown by Konno (2009) [21], we observed that
only until 2 h both, P4 and P23 significantly down-regulated NOliberation by BMM stimulated with zymosan particles. After 4,
8 and 12 h NO levels had no significant difference between
groups (data not shown).
Altogether these results suggest that P4 and P23 appear to
modulate the mRNA expression and production of important
inflammatory mediators, hence promoting reduction of the
initial effects of the inflammatory process.3.5. Effect of peptides in vivo using different protocolsConsidering the systemic inhibitory effect of P4 and P23
observed in vivo, we investigated whether different adminis-
tration protocols could improve the anti-inflammatory effects
of P4 and P23. First, we determined duration of anti-
inflammatory effects of P4 and P23 after administration. We
found that after 24 h of administration of P4 or P23 no effect
of peptides was observed (data not shown). We then verified
systemic effects of P4 and P23 in longer times. For this, Balb/c
mice infected with P. brasiliensis in the footpads received
every 8 h P4 or P23 intraperitoneally (100 mg). Footpad
Fig. 3. Evaluation of mRNA expression and production of pro-inflammatory cytokines in macrophages stimulated with zymosan particles in presence or not of P4
or P23. The methods used were qPCR and ELISA respectively. mRNA expression was done 2 or 8 h after stimulus with zymosan particles and ELISA was
performed after 2, 4, 8 and 12 h after stimulus with zymosan. Control group were macrophages only stimulated with zymosan. (A) TNF-a mRNA expression and
(B) dosage of TNF-a secreted by BMM. (C) IL6 gene expression and (D) IL6 secreted by BMM. P* < 0.05, P** < 0.01 and P*** < 0.001 when values were
compared with control group. Results are representative of at least two individual experiments.
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decrease in FTP swelling indexes was observed along the 3
days tested (Fig. 5A). These results showed that P4 and P23
are able to keep the anti-inflammatory effect whenFig. 4. Evaluation of anti-inflammatory IL10 involved in inflammation. Macropha
mRNA expression was done 2 or 8 h after stimulus with zymosan particles and E
methods used were qPCR and ELISA respectively; control group were macrophage
IL10 secreted by BMM. Importance of IL10 in vivo was performed with KO-IL10
P23. Treatment with P4 and P23 on the evolution of P. brasiliensis cells-induced ede
P* < 0.05, P** < 0.01 and P*** < 0.001 when values were compared with contadministered continuously (Fig. 5A). Moreover, histological
analyses to detect P. brasiliensis confirmed again that P4 and
P23 promote increased areas with fungi after treatment
(Fig. 5B).ges were stimulated with zymosan particles in presence or not of P4 or P23.
LISA was performed after 2, 4, 8 and 12 h after stimulus with zymosan. The
s stimulated with zymosan only. (A) IL10 mRNA expression and (B) dosage of
mice infected in the footpad with P. brasiliensis and treated or not with P4 or
mas in footpad of (C) C57/bl6 mice or (D) in KO-IL10 mice (n ¼ 5 per group).
rol group. Results are representative of at least two individual experiments.
Fig. 5. Effect of long term treatment with P4 and P23 on the evolution of P. brasiliensis-induced edemas (A) in the footpad of mice (n ¼ 5 per group). Negative
control group (Cneg) received PBS in the footpad and was also treated intraperitonealy with PBS. Positive control (Cpos), P4 and P23 groups was infected P.
brasiliensis and treated intraperitonealy with PBS, P4 or P23 respectively. Administration of P4, P23 or PBS was performed every 8 h for 3 days. (B) Histological
analyses of P. brasiliensis cells stained by Grocott (100) and quantification of area with P. brasiliensis cells (8 h after infection and treatment) done with Image J
software. Results are representative of 2 independent experiments. P* < 0.05, P** < 0.01 and P*** < 0.001 when values were compared with control group.
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different routes of administration, we treated Balb/c mice with
P. brasiliensis infected footpads with 200 mg of P4 or P23
intraperitoneally or injected the peptides (100 mg) into the tail
vein. Both groups showed significant decrease in FTP swelling
indexes (Fig. 6A,B,C,D). Further, these smaller FTP swellings
were observed earlier (in 2 h after the peptides administration)
than the previous experimental conditions. These smaller in
footpad swelling indexes were also maintained for longer
periods (Fig. 6 A,B,C,D).
4. Discussion
Gp43 plays different roles in the pathogenesis P. brasi-
liensis. Our group demonstrated that gp43 down regulates
macrophage functions in vitro [18] and that two peptides (P4and P23), derived from gp43, inhibit phagocytosis of zymosan
particles and P. brasiliensis yeast by macrophages [21]. These
data suggested that gp43, or more specifically P4 and P23
peptides, could facilitate the establishment and dissemination
of P. brasiliensis in the initial phase of infection.
Gp43 also has a role in the protection mechanisms against
the fungus, since subcutaneous infection with whole yeasts,
led to immune protection or exacerbated disease depending on
the route of challenge [38]. The protective effect of gp43 was
confirmed after immunization with peptide P10, derived from
its sequence, which also promoted protection in animal model
[16]. This has been one of few examples in which a short
sequence of the whole molecule could be correlated with one
very specific function. These distinct responses by the same
glycoprotein are due to different peptides of gp43 acting at
different times of the immune response.
Fig. 6. Effect of different administration protocols of P4 and P23 on the evolution of P. brasiliensis-induced edemas in the mice footpads. Mice infected in the
footpad with P. brasiliensis were treated with higher dose of P4 and P23 (200 mg) or with peptides (100 mg) administrated in tail vein (n ¼ 5 per group). (A)
Treatment with increased dose of P4 (B) or P23. Administration of P4 (C) or (D) P23 in tail vein. Negative control (Cneg), P4 control (CP4) and P23 control
(CP23) groups received PBS both in the footpads and as treatment, P4 or P23 respectively. Positive control (Cpos), P4 and P23 groups were infected P. brasiliensis
and treated intraperitonealy with PBS, P4 or P23 respectively. Results are representative of 2 independent experiments. P* < 0.05, P** < 0.01 and P*** < 0.001
when values were compared with control group.
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play important roles in the early host response to pathogens
[39]. Macrophages are part of the innate immune response
constituting the first line of defense against invading patho-
gens. They are involved in recognition, phagocytosis and
destruction of many organisms.
In addition, macrophages are also involved in antigen
presentation and secretion of a wide variety of products,
including enzymes, enzyme inhibitors, cytokines, chemokines,
among others [40]. Thus, P4 and P23 might interfere in
macrophages functions by modifying production and expres-
sion of molecules involved in inflammation.
Recently, it has become evident that some endogenous
peptides, generally named Antimicrobial Peptides (AMPs),
can also act as immune modulators and that their production
may depend on the host immune response to infections,
involving inflammation and vascular effects [19].
Our laboratory has shown that peptides derived from P.
brasiliensis full sequence could interfere with the pathoge-
nicity of this mycosis [23]. Other peptide named KP derived
Killer toxin (KT) from Pichia anomala exert microbicidal
activity over other microorganisms showing KT receptor
(KTR) [24].
Peptides P4 and P23 can be regarded as AMPs, assuming
that their inhibitory effect on macrophages [21] might be due
to the fact that they can be acting as immune modulators. We
then investigated some mechanisms by which P4 and P23 areinvolved in reducing the inflammatory response, attempting to
further understand their roles on macrophage activities.
To understand the immunoregulatory phenomena involved
in the action of P4 and P23, we analysed anti- and pro-
inflammatory molecules produced by macrophages, such as
mRNA expression and production of TNF-a. TNF-a is
a pleiotropic cytokine produced by different types of cells.
However, cells of the monocytic lineage, such as macro-
phages, are its primary synthesizers [41]. TNF-a is a powerful
pro-inflammatory agent, rapidly released after infection, that
regulates many facets of macrophage functions [42]. Results
suggested that P4 and P23 delayed the production of TNF-a
by macrophages, which could be related with inhibitory
effects on macrophages early in inflammation [21].
IL6 is an important pleiotropic pro-inflammatory cytokine
that regulates immunological reactions, participating in host
defense, inflammation, haematopoiesis and oncogenesis [43].
P4 and P23 also had influenced in mRNA expression of IL6. In
their presence we observed increase of IL6 mRNA expression
8 h after stimulation with zymosan. Furthermore, P4 and P23
seem to induce increased production of IL6 as compared with
control group in all evaluated times. Such IL6 increase could
be a compensation mechanism for to the delay in the
production of TNF-a, also a pro-inflammatory cytokine
secreted in the early inflammatory process.
IL10 is the most important anti-inflammatory cytokine
whose most important sources in vivo seem to be monocytes
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inflammatory mediators and inhibits antigen presentation [44].
As P4 and P23 seem to be anti-inflammatory peptides, we
studied their effect on mRNA gene expression and production
of IL10. In macrophages they seem more precocious in groups
treated with P4 and P23 since the control group only presented
a small increase in the levels of IL-10 8 h after stimulation.
IL10 blocks activation of cytokine synthesis and several
accessory cell functions, rendering this cytokine a potent
suppressor of effector functions of macrophages and other
immune cells [42]. This fact could explain exacerbated
increase of IL6 while there is decreased production of IL10.
We also checked molecules involved in innate immunity,
such as Toll like receptor 2 (TLR2) and NO. TLR are trans-
membrane proteins that interact with invariant molecular
structures from pathogens (PAMPs) [45]. Expression of TLRs
is modulated during inflammation mainly by molecules such
as those cytokines previously evaluated. Flow cytometry
analysis showed that expression of TLR2 was delayed in
treated groups as compared to control group (data not shown).
Delayed expression of TLR2 in BMM treated with peptides
seems to be related to the inhibitory effect of peptides since
TLRs are directly involved with activation of innate immunity
[43]. Moreover, these receptors appear to be used by P. bra-
siliensis yeast cells to gain access into macrophages and to
escape from other fungicidal or fungistatic mechanisms of
innate immunity [46]. Thus, delayed expression of TLR2 in
BMM could be associated with inhibitory effect in phagocytic
potential of macrophages in the presence of our peptides [21].
Activated macrophages migrate to sites of inflammation
where they encounter and lyse pathogens. This is accom-
plished by an increased production of toxic oxygen species
and via induction of nitric oxide synthase (iNOS) to produce
nitric oxide (NO) [47]. Konno et al. (2009) [21] demonstrated
that P4 and P23 down-regulated NO liberation by bone
marrow macrophages stimulated with zymosan particles after
incubation for 1 h 30 min. We here observed that after 2 h
both, P4 and P23, significantly down-regulated NO liberation
by BMM stimulated with zymosan particles. After 2 h no
difference was observed (data not shown).
Summing up, P4 and P23 modulate production of important
inflammatory mediators promoting reduction of the beginning
inflammatory process.
Considering the inhibitory effect of P4 or P23 in inflam-
mation observed in vitro and in vivo [21], we then investigated
whether P4 and P23 showed any systemic effect in vivo on the
kinetics of inflammation. Results of footpad swelling test (FPT)
showed decreased indexes in the first 12 h after inoculation of P.
brasiliensis cells in different strains of mice. Only in KO-IL10
mice, no effect of P4 and P23 was observed. This finding
suggests again the importance of IL10 in the participation of P4
and P23 in inflammation. Furthermore, histological analysis to
quantify P. brasiliensis yeasts in the footpad of the infected
mice showed that the treated groups presented higher amounts
of fungi. These results combined with results of Konno et al.
(2009) [21] suggest that P4 and P23 are able to inhibit the
phagocytic ability of macrophages thereby facilitating fungalgrowth. In conclusion, P4 and P23 showed systemic anti-
inflammatory effect and seem to inhibit the phagocytic func-
tion of macrophages thereby facilitating fungal growth in
different models here studied. Similar results were seen when
using infection with BCG, suggesting that the anti-
inflammatory effect of peptides is not restricted to the PCM
model. Additionally, Konno et al., 2009 [21] demonstrated by
Jameson Wolff (Protean software) analyses that P23 has low
antigenic indexes whereas P4 show antigenic indexes slightly
higher in its N-terminal region. P4 and P23 have no epitopes that
could be presented to T cells. So, according with these char-
acteristics of P4 and P23 observed in silico analyses and bio-
logical effects, we assumed that the peptides do not elicit
specific immune response. If I was so, an immune response to
the fungus in presence of P4 or P23 would be more similar to
control group. Moreover, when we evaluated production of
cytokines in vivo in sera of mouse infected in footpad with P.
brasiliensis and treated or not intraperitoneally with P4 or P23,
we found no difference in production of systemic IL6, TNF-a
and IL10 between groups in any of the times evaluated (2, 4, 8,
12 h) (data not shown). These results suggest that P4 and P23
can act only in the inflammatory focus and that they are not able
to alter cytokine production systemically. We then evaluated
whether continuous treatment with peptides could maintain the
reduced inflammation. Our findings demonstrated that treat-
ment with P4 and P23 every 8 h induced continuous anti-
inflammatory effects during the evaluated period. Moreover,
P4 and P23 administered in higher doses or intravenously had
improved effects since their anti-inflammatory action was
observed earlier and lasted longer. Because P4 and P23 are
exposed at the gp43 molecule surface [21], it can be assumed
that they could be responsible for the role as immunemodulator.
Moreover, findings here presented demonstrated that P4 and
P23 have a potent effect on the inhibition of inflammation
through modulation of inflammatory molecules. Additionally,
analyses of peptides by BLAST-R [http://blast.ncbi.nlm.nih.
gov/Blast] showed that P4 have no homology with any puta-
tive conserved domain of human proteins (Homo sapiens Taxid
9606). P23 have low homology with HCG1779566 protein
CRA isoform whose product and function are unknown
(hypothetical proteins) (score of 28.2 bits, identity of 9/13 and
e-value of 0.001) and with VDJ regions of the immunoglobulin
heavy chain (score of 26.9 bits, 6/7 of identity and e-value of
0.002). Our findings open the possibility, after better under-
standing and characterization of P4 and P23, that these mole-
cules may have application in the general practice. This will
depend on better understanding of their pharmacological
actions, on increasing their stability in the circulation and on
better evaluation of their possible toxicity in parallel with the
time and dosing for ideal anti-inflammatory results.Acknowledgements
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